Consortium to map SNPs for clinical application
An unprecedented consortium of ten global pharmaceutical companies, the UK's Wellcome Trust, and five research institutes will pool their resources to draw up a $45m (£30m) map of the variations in the human genetic code, or single-nucleotide polymorphisms (SNPs). This alliance, called the SNP Consortium, also announced last week that...
Comment
Is the SNP consortium philanthropy in action?
by Professor Marcus Pembrey
The Wellcome Trust is to fund 67% of a two year, $45m (£30m), international project to define some 300,000 DNA sequence variations in the human genome. The remaining funds come from a consortium of ten of the world's leading pharmaceutical companies, who have also agreed to put the newly discovered...